rs2240017
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000177694.2(TBX21):c.99C>G(p.His33Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0308 in 1,487,136 control chromosomes in the GnomAD database, including 1,068 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000177694.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX21 | NM_013351.2 | c.99C>G | p.His33Gln | missense_variant | 1/6 | ENST00000177694.2 | NP_037483.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX21 | ENST00000177694.2 | c.99C>G | p.His33Gln | missense_variant | 1/6 | 1 | NM_013351.2 | ENSP00000177694 | P1 | |
TBX21 | ENST00000581328.1 | n.129C>G | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0301 AC: 4577AN: 152020Hom.: 156 Cov.: 32
GnomAD3 exomes AF: 0.0488 AC: 4004AN: 82008Hom.: 164 AF XY: 0.0474 AC XY: 2231AN XY: 47062
GnomAD4 exome AF: 0.0309 AC: 41282AN: 1335008Hom.: 911 Cov.: 31 AF XY: 0.0317 AC XY: 20884AN XY: 658392
GnomAD4 genome AF: 0.0302 AC: 4588AN: 152128Hom.: 157 Cov.: 32 AF XY: 0.0315 AC XY: 2343AN XY: 74366
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 22% of patients studied by a panel of primary immunodeficiencies. Number of patients: 21. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at